Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis

J Antimicrob Chemother. 2021 Feb 11;76(3):820-822. doi: 10.1093/jac/dkaa507.

Amondrea Blackman^{1

2}, Bob Morrison³, Fernanda Maruri^{1

2}, Yuri van der Heijden^{1

2

4}, Cindy Hager Nochowicz^{1

2}, Yan Guo⁵, Matthew Scholz⁶, Tige Rustad³, David R Sherman^{3

7}, Timothy R Sterling^{1

2}

¹ Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
² Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
³ Seattle Children's Hospital, Seattle, WA, USA.
⁴ The Aurum Institute, Johannesburg, South Africa.
⁵ University of New Mexico, Albuquerque, NM, USA.
⁶ Vanderbilt Technologies for Advanced Genomics (VANTAGE) Core, Vanderbilt University Medical Center, Nashville, TN, USA.
⁷ Department of Microbiology, University of Washington, Seattle, WA, USA.

No abstract available

Publication types